Table…… Demographic characteristics of hypertensive patients

Variable n (%)
Sex
Male 158 (40)
Female 235 (60)
Total 393 (100)
Age
35-39 3 (0.76)
40-44 5 (1.27)
45-49 15 (3.8)
50-54 25 (6.36)
55-59 59 (15)
60-64 83 (21.1)
65-69 85 (21.6)
70-74 60 (15.3)
75-79 45 (11.5)
≥ 80 22 (5.6)
Total 393 (100)
Mean ± SD. 65.3±9.8
Median (Maximum-Minimum) 65(99-37)
Body weight (kg)
Mean ± SD. 65.61±13.5
Median (Maximum-Minimum) 64.5(117.4-33.1)
Body Height (cm)
Mean ± SD. 158.1±9.2
Median (Maximum-Minimum) 156.9(186-138)
BMI (kg/m2)
< 18.5 (underweight) 6 (1.5)
18.5-22.9 (normal) 85 (21.6)
23.0-24.9 (overweight) 61 (15.5)
25.0-29.9 (pre-obesity) 104 (26.5)
≥ 30 (obesity) 68 (17.3)
No data 69 (17.6)
Total 393 (100)

Variable n (%)
 Mean ± SD. 26.2±4.9
Median (Maximum-Minimum) 25.3 (42.0-15.2)
Religion
Buddhism 370 (94.1)
Christianity 1 (0.3)
Islamism 18 (4.6)
Hinduism 2 (0.5)
No data 2 (0.5)
Total 393 (100)
Occupation
None 155 (39.4)
Farmer/Agriculturalist 69 (17.6)
Government official 42 (10.7)
Fisherman 2 (0.5)
Business owner 47 (12.0)
Company employee 2 (0.5)
Laborer 70 (17.8)
State enterprise officer 6 (1.5)
Total 393 (100)
Health insurance
Universal coverage scheme 130 (33.1)
Social security scheme 14 (3.6)
Government enterprise officer 199 (50.6)
State enterprise officer 13 (3.3)
Pay cash 37 (9.4)
Total 393 (100)

Smoking
Current smoker 16 (4.1)
Former smoker 31 (7.9)
Non-smoker 83 (21.1)
No data 263 (66.9)
Total 393 (100)
Variable n (%)
Alcohol drinking
Current alcohol drinker 21 (5.3)
Former alcohol drinker 16 (4.1)
No alcohol drinking 39 (9.9)
No data 317 (80.7)
Total 393 (100)
Traditional herbal usage
Used 6 (2)
Not used 17 (4)
No data 370 (94)
Total 393 (100)
Table…. Clinical characteristics of hypertensive patients
Variable n (%)
Time developed hypertension (year)
<5 60 (15)
5-15 219 (56)
> 15 28 (7)
No data 87 (22)
Total 393 (100)
Follow up episodes (times)
<2 13 (3.3)
≥2 380 (96.7)
Total 393 (100)
Hypertensive medication
None 36 (9.2)
ARB 84(21.4)
CCB 196(49.9)
Diuretics 107 (27.2)
Beta blocker 88 (22.4)
ACE inhibitors 112 (28.5)
Alpha blocker 10(2.5)
Other 0 (0)
Total 636
Diabetic medication
 None 12(8.2)
Biguanides 122(83.6)
Sulfonylurea 66(45.2)
Thiazolidinodione 31(21.2)
Alpha-glucosidase inhibitor 0(0)
DDP-4 Inhibitor 3(2.1)
Insulin 13(9)
Other 0(0)
Total 247

Variable n (%)
Dyslipidemic medication
None 38(15)
Statin 209(82.6)
Fibrates 6(2.4)
Niacin 0
Other 0
Total 253
Comorbidity
None 33(8.4)
Diabetes mellitus
type 1 4(1)
type 2 142(36.1)
Hyperlipidemia 253(64.4)
CKD 5(1.3)
Other 43(11)
Total 480
Table…… Univariate regression analysis of factors affecting blood pressure control in hypertensive
patients

Variable Controlled Uncontrolled OR 95% CI. P-value

BP BP
(n=207) (n=186)
Male, n (%) 82 (40) 76 (41) 1.1 0.7-1.6 0.67
Female, n (%) 125 (60) 110 (59) 1
Age (year), n (%)
<50 9 (4.3) 14 (7.5) 1
50-59 42 (20.3) 40 (21.5) 0.6 0.24-1.57 0.31
60-69 91 (44.0) 70 (37.6) 0.5 0.20-1.21 0.12
70-79 56 (27.1) 49 (26.3) 0.6 0.22-1.41 0.22
≥80 9 (4.3) 13 ( 0.9 0.28-3.06 0.9
BMI
<18.5 5 1 1 - -
18.5-22.9 49 36 3.6 0.4-32.8 0.24
23-24.9 35 26 3.7 0.4-33.7 0.24
25-29.9 57 47 4.1 0.5-36.5 0.20
≥30 25 43 8.6 1.0-77.8 0.05
Time developed hypertension
<5 79 76 1
5-15 126 93 0.8 0.5-1.2 0.21
>15 11 17 1.6 0.7-3.7 0.25
Follow up episodes
≥6 29 28 1
4-5 119 90 0.8 0.4-1.4 0.41
≤3 59 65 1.1 0.6-2.1 0.68
ARB 35 49 1.8 1.1-2.9 0.02
CCB 104 92 1 0.7-1.5 0.98
Diuretics 55 52 1.1 0.7-1.7 0.70
Beta blocker 45 43 1.1 0.7-1.8 0.70
ACE Inhibitor 47 65 1.9 1.2-2.9 0.006
Alpha blocker 3 7 2.7 0.7-10.6 0.15
Type of drugs
0 24 12 1
1 97 87 1.8 0.8-3.8 0.12
2 76 58 1.5 0.7-3.3 0.28
3 14 22 3.1 1.2-8.2 0.02
4 2 10 10.0 1.9-53.1 0.006
Diabetes mellitus 41 105 5.2 3.4-8.2 <0.001
Hyperlipidemia 139 114 0.8 0.5-1.2 0.31
CKD 3 2 0.8 0.1-4.5 0.75
Cerebrovascular accident 24 15 0.6 0.3-1.2 0.12
Cardiovascular disease 25 10 0.4 0.2-0.9 0.03
Renal complication 45 38 0.9 0.6-1.5 0.8
Fasting plasma glucose
<100 76 35 1
100-125 66 54 1.8 1.0-3.0 0.03
≥126 20 61 6.6 3.5-12.6 <0.001
Cholesterol
<200 129 121 1
200-239 43 32 0.8 0.5-1.3 0.38
≥240 13 16 1.3 0.6-2.8 0.49
HDL-C
>=50 110 76 1
<50 40 39 1.5 0.9-2.6 0.11
<40 17 25 2.1 1.1-4.1 0.03

LDL-C
<100 59 50 1
>=100 126 108 1 0.6-1.5 0.84
>=200 3 8 2.9 0.7-11.6 0.12

Triglyceride
<150 131 113
>=150 55 54 0.61

Albuminuria
<30 52 47 1
30-300 15 19 1.4 0.6-3.1 0.40
>300 2 2 1.1 0.1-8.2 0.90